Neurocrine stocks up on a biotech’s psychiatric drugs
Neurocrine is perhaps best known for its work in movement disorders and women's health, having developed approved medications for tardive dyskinesia and the pain asso...
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement